These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 36291080)

  • 1. Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications.
    Heestermans M; Poenou G; Hamzeh-Cognasse H; Cognasse F; Bertoletti L
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
    Beyer-Westendorf J; Ageno W
    Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of target-specific oral anticoagulants for the acute and long-term treatment of venous thromboembolism.
    Akwaa F; Spyropoulos AC
    Curr Med Res Opin; 2014 Nov; 30(11):2179-90. PubMed ID: 25105309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
    Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
    Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of heparin lead-in in the real-world management of acute venous thromboembolism: The PREFER in VTE registry.
    Bauersachs R; Agnelli G; Gitt AK; Monreal M; Mismetti P; Willich SN; Laeis P; Fronk EM; Bramlage P; Cohen AT;
    Thromb Res; 2017 Sep; 157():181-188. PubMed ID: 28780343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Overview of Direct Oral Anticoagulants for the Management of Venous Thromboembolism.
    Comerota AJ; Ramacciotti E
    Am J Med Sci; 2016 Jul; 352(1):92-106. PubMed ID: 27432042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of venous thromboembolism in patients with cancer: What news from clinical trials?
    Verso M; Franco L; Giustozzi M; Becattini C; Agnelli G
    Thromb Res; 2018 Apr; 164 Suppl 1():S168-S171. PubMed ID: 29703477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant selection for patients with VTE-Evidence from a systematic literature review of network meta-analyses.
    Cohen AT; Berger SE; Milenković D; Hill NR; Lister S
    Pharmacol Res; 2019 May; 143():166-177. PubMed ID: 30905806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic Therapies in Anticoagulation.
    Ferreira JL; Wipf JE
    Med Clin North Am; 2016 Jul; 100(4):695-718. PubMed ID: 27235611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism management: where do novel anticoagulants fit?
    Spyropoulos AC; Turpie AG
    Curr Med Res Opin; 2013 Jul; 29(7):783-90. PubMed ID: 23659584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated partial thromboplastin time monitoring in patients receiving unfractionated heparin for venous thromboembolism in relation to clinical outcomes.
    Vardi M; Laor A; Bitterman H
    Thromb Haemost; 2009 Nov; 102(5):879-86. PubMed ID: 19888523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulants in the management of venous thromboembolism.
    Makaryus JN; Halperin JL; Lau JF
    Nat Rev Cardiol; 2013 Jul; 10(7):397-409. PubMed ID: 23689703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant Medications for the Prevention and Treatment of Thromboembolism.
    Brien L
    AACN Adv Crit Care; 2019; 30(2):126-138. PubMed ID: 31151944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic drugs: part I.
    Gallus AS; Hirsh J
    Drugs; 1976; 12(1):41-68. PubMed ID: 789043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.
    Gómez-Outes A; Lecumberri R; Suárez-Gea ML; Terleira-Fernández AI; Monreal M; Vargas-Castrillón E
    J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):490-500. PubMed ID: 25802423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Thromboprophylaxis: A Systematic Review of the Literature.
    Branstetter JW; Kiskaddon AL; King MA; Coalter C; Grubbs KM; Fly H; Male C; Brandão L; Goldenberg NA
    Semin Thromb Hemost; 2021 Sep; 47(6):643-653. PubMed ID: 33971679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants.
    Vedovati MC; Giustozzi M; Becattini C
    Thromb Res; 2019 May; 177():33-41. PubMed ID: 30849513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel anticoagulant therapy: principle and practice.
    Mousa SA
    Methods Mol Biol; 2010; 663():157-79. PubMed ID: 20617417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.